NeuroInsight data analytics training programme awarded €4.7m

Prof Gianpiero Cavalleri
Prof Gianpiero Cavalleri

Programme combines expertise from RCSI, Science Foundation Ireland centres

Print

PrintPrint
Life

Read More:

5 May 2021 | 0

NeuroInsight has been awarded a Marie Skłodowska-Curie Actions (MSCA) COFUND worth €4.7 million. Led by RCSI University of Medicine and Health Sciences, the new research training programme will see scientists from around the world working in Ireland to develop advanced data skills for research into neurological conditions including motor neuron disease, epilepsy and Parkinson’s disease.

The NeuroInsight Fellowship programme has been established by RCSI-hosted FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Disease, in partnership with Insight, the SFI Research Centre for Data Analytics. The two centres will deliver an integrated and applied training programme for research fellows, building upon respective health and data analytics expertise available across the two SFI centres. Collectively, FutureNeuro and Insight already support over 500 researchers who are working on a new generation of neuroscience and data analytics technologies.

People living with neurological conditions will be at the core of the programme, with all projects under the scheme designed with input from patients at the outset. The researchers will also be seconded to hospital and industry settings during their fellowships, to ensure their findings are transferable to devices, diagnostics or treatments that ultimately improve the lives of people impacted by neurological disease.

 

advertisement



 

NeuroInsight will offer 24-month fellowships to 33 experienced researchers from around the world who will work on projects across the FutureNeuro and Insight centres. The programme will equip this future generation of research leaders with competencies in fields such as precision medicine and artificial intelligence.

“As a society, and particularly in our healthcare systems, we are generating more and more data, insights from which can help us better understand and treat neurological disease,” said NeuroInsight programme lead, Prof Gianpiero Cavalleri, deputy director of FutureNeuro and professor of Human Genetics at RCSI School of Pharmacy and Biomolecular Sciences. “This programme is about training and equipping the next generation of researchers to safely and effectively engage with these datasets in a manner that positively impacts on the lives of people with neurological conditions.

“NeuroInsight is a significant programme that will bring together Ireland’s leading researchers in the fields of neurosciences, e-health and data analytics. Partnering with the Insight Centre, we will work to create a culture of patient-centric entrepreneurship that will ultimately transform the patient journey for people with chronic and rare neurological conditions.”

“Data analytics and Artificial Intelligence are now at the core of much of our work, our leisure and our health activities though it is not always obvious and apparent that they are being used in our day-to-day lives,” added Prof Alan Smeaton, Academic Lead for NeuroInsight from the Insight Centre. “There is huge opportunity to work with our colleagues in FutureNeuro and with patient organisations to apply such techniques to improve the lives of people living with neurological conditions and we look forward to meeting the challenges and making an impact.”

Prof Mark Ferguson, director general of Science Foundation Ireland and chief scientific adviser to the Government of Ireland, said “The NeuroInsight Fellowship programme confirms Ireland’s position as a European leader in advanced research training. The significant funding that the NeuroInsight programme has attracted is a testament to the critical mass of expertise brought together by FutureNeuro and Insight and highlights the world class standard of our SFI Research Centres. This collaboration will influence the lives of many people living with neurological conditions for years to come.”

For more on NeuroInsight visit bit.ly/NeuroInsight  

TechCentral Reporters

Read More:



Comments are closed.

Back to Top ↑